Royal Lifescience Corp. Terminates Qualifying Transaction
1870 – 400 Burrard Street Vancouver, British Columbia V6B 3K1
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
ROYAL LIFESCIENCE CORP. TERMINATES QUALIFYING TRANSACTION
February 27, 2014 TSX Venture Exchange Trading Symbol: RLS.P
Vancouver, British Columbia – Royal Lifescience Corp. (the “Company”), a capital pool company pursuant to Policy 2.4 of the TSX Venture Exchange (the “TSXV”), announces that it has terminated its Qualifying Transaction with Nanocrystal Technology Inc. (“Nanocrystal”), previously announced on September 6, 2012, due to a variety of factors, including volatile and declining economic conditions and a significant delay in the due diligence review of Nanocrystal.
The Company will continue to pursue other opportunities with a view to completing a Qualifying Transaction under the CPC policy of the TSXV.
The common shares of the Company are expected to resume trading on the TSXV upon receiving TSXV approval.
On behalf of the Board of Directors
“Craig D. Thomas”
Craig D. Thomas Chief Executive Officer, Chief Financial Officer, Director
For further information please contact:
Craig D. Thomas Telephone: (604) 688-6775
Neither the TSX Venture Exchange not its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
Certain statements in this news release are forward-looking statements, which reflect the expectations of management regarding the Company’s listing of its common shares on the TSX-V. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. No assurance can be given that any of the events anticipated by the forward-looking statements will occur, or if they do occur, what benefits the Company will obtain from them.